[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
[ Wed, May 04th 2022 ]: WOPRAI
Mike Matson Maintained (ATRC) at Strong Buy with Decreased Target to $67 on, May 4th, 2022
🞛 This publication is a summary or evaluation of another publication
Mike Matson of Needham, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Decreased Target from $79 to $67 on, May 4th, 2022.
Mike has made no other calls on ATRC in the last 4 months.
There is 1 other peer that has a rating on ATRC. Out of the 1 peers that are also analyzing ATRC, 0 agree with Mike's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mike
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $88 on, Wednesday, February 16th, 2022